Apolipoprotein(a) and thrombosis: Molecular and genetic bases of hyper- lipoprotein(a)-emia

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 3, 1998, Pages 237-243

  Ichinose, Akitada ^a   Suzuki, Koji ^a   Saito, Tetsuo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein(a); Atherosclerosis; Gene regulation; Lipoprotein(a); Thrombosis

Indexed keywords

APOLIPOPROTEIN A; INSULIN; LIPOPROTEIN A; ORAL ANTIDIABETIC AGENT; PLASMINOGEN;

ATHEROGENESIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; HUMAN; HYPERLIPOPROTEINEMIA; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOGENICITY;

EID: 0031869089     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995848     Document Type: Conference Paper

References (30)

1. Berg K. A new serum type system in man - The LP(a) system. Acta Pathol Microbiol Scand 1963;59:369-382
2. Utermann G. The mysteries of lipoprotein(a). Science 1989;246: 904-910
3. Miles LA, Plow EF. An interloper into the fibrinolytic system? Thromb Haemostas 1990;63:331-335
4. McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-137
5. Ichinose A. Multiple members of plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry 1992; 31:3113-3118
6. Ichinose A. Characterization of the apolipoprotein(a) gene. Biochem Biophys Res Commun 1995;209:365-371
7. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-2544
8. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204
9. Ichinose A, Espling ES, Takamatsu J, et al. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 1991;88:115-119
10. Tsutsumi S, Saito T, Sakata T, Miyata T, Ichinose A. Genetic diagnosis of dysplasminogenemia: Detection of an Ala601-Thr mutation in 118 out of 125 families. Thromb Haemostas 1996;76: 135-138
11. Byrne CD, Schwartz K, Meer K, Cheng J-F, Lawn RM. The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver. Arterioscler Thromb 1994;14:534-541
12. Weissbach L, Treadwell BV. A plasminogen-related gene is expressed in cancer cells. Biochem Biophys Res Commun 1992; 186:1108-1114
13. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328
14. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 1996;22:689-692
15. Byrne CD, Schwartz K, Lawn RM. Loss of splice donor site at a "skipped exon" in a gene homologous to apolipoprotein(a) leads to an mRNA encoding a protein consisting of a single kringle domain. Arterioscler Thromb Vasc Biol 1995;15:65-70
16. Wade DP, Lindahl GE, Lawn RM. Apolipoprotein(a) gene transcription is regulated by liver-enriched trans-activating factor hepatocyte nuclear factor 1α. J Biol Chem 1994;269:19757-19765
17. Magnaghi P, Citterio E, Malgaretti N, et al. Molecular characterization of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6 (6q26-27). Hum Mol Genet 1994;3:437-442
18. Velho G. Erlich D, Turpin E, et al. Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 1993;16:742-747
19. Jenkins AJ, Best JD. The role of lipoprotein(a) in the vascular complications of diabetes mellitus. J Intern Med 1995;237: 359-365
20. Ridker PM, Stampfer MJ, Henneckens CH. Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 1995;273: 1269-1273
21. Saito T, Ookubo R, Kuriyama M, Sano R, Ichinose A. Lipoprotein(a) concentration and molecular weight of apolipoprotein(a) in patients with cerebrovascular disease and diabetes mellitus. Thromb Res 1997;87:527-538
22. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21:637-676
23. Lind H, Nisson P, Holthuis N, Lindholm L. Non-obese men with high lipoprotein(a) values - A cardiovascular risk group different from those with the metabolic syndrome? Scand J Clin Lab Invest 1994;54:177-183
24. Duell PB, Hagemenas F, Connor WE. The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care 1994;17:1135-1140
25. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem 1991;266:2459-2465
26. Rader DJ, Cain W, Ikewaki K, et al. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to difference in Lp(a) catabolism but to differences in production rate. J Clin Invest 1994;93:2758-2763
27. Ichinose A, Kuriyama M. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein(a). Biochem Biophys Res Commun 1995;209:372-378
28. Suzuki K, Kuriyama M, Saito T, Ichinose A. Plasma Lp(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 1997;99:1361-1366
29. Zysow BR, Lindahl GE, Wade DP, Knight BL, Lawn RM. C/T polymorphism in the 5′-untranslated region of the apolipoprotein(a) gene introduces an upstream ATG And reduces in vitro translation. Arterioscler Thromb Vasc Biol 1995;15:58-64
30. Mooser V, Mancini FP, Bopp S, et al. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet 1995;4:173-181